Long non-coding RNAs (lncRNAs) play a vital role in a variety of biological functions in plant growth and development. In this study ... LncRNAs function through playing multiple roles, including ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Welcome to the 3 rd Annual RNAi – Based Therapeutics Summit: Overcoming Barriers for Targeted siRNA Therapeutics Built with biopharmaceutical industry insights, this in person conference will ...

He hunts for downtrodden cyclical firms whose market expectations are undeservedly gloomy and secular-growth companies whose magnitude or duration of growth is underappreciated. That framework is ...

Growth stocks are made up of companies that are set to grow their earnings and revenue by an abundant amount compared to the rest of the market, which also has an impact on the price of each ...

This review aims to critically appraise the available literature on interactions involving nanomaterials, plants, and microorganisms. This review explores the role of nanomaterials in enhancing plant ...

The Vietnam RNAi Therapeutics market is undergoing robust growth, fueled by factors such as advancements in RNA interference (RNAi) technology, a growing understanding of gene silencing mechanisms, ...

It combines AI-driven automated environmental control, integrated plant monitoring, and energy-efficient engineering to optimize growth conditions. By using its capsule-based system and adjusting ...

The portfolio is very likely to remain in the large-growth section of the Morningstar Style Box and keep most of its assets in the technology, consumer, and communications sectors. These sectors ...

The FDA has approved the first ever RNA interference drug – Alnylam’s Onpattro (patisiran) for the nerve damage caused by the rare disease hereditary transthyretin-mediated amyloidosis (hATTR ...